Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

about

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q42068309

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@en

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@nl

type

Item

label

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@en

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@nl

prefLabel

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@en

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@nl

P1476

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

@en

P2093

Jia-Hong Wang

http://www.w3.org/2001/XMLSchema#string

Min-Shan Chen

http://www.w3.org/2001/XMLSchema#string

Ming Shi

http://www.w3.org/2001/XMLSchema#string

Pei-En Jian

http://www.w3.org/2001/XMLSchema#string

Rong-Ping Guo

http://www.w3.org/2001/XMLSchema#string

Shao-Hua Li

http://www.w3.org/2001/XMLSchema#string

Wei Wei

http://www.w3.org/2001/XMLSchema#string

Xiao-Liang Wu

http://www.w3.org/2001/XMLSchema#string

Xiao-Ping Zhong

http://www.w3.org/2001/XMLSchema#string

Yi-Hong Ling

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Epithelial-mesenchymal transitions in tumour progression

A novel type of deubiquitinating enzyme

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Hepatocellular carcinoma

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

Epithelial mesenchymal interactions in cancer and development.

Risk of HCC: genetic heterogeneity and complex genetics.

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.

P304

e3043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2017.428

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28880268

http://www.w3.org/2001/XMLSchema#string

P932

5636974

http://www.w3.org/2001/XMLSchema#string